跳至主要内容
临床试验/TCTR20190222004
TCTR20190222004已完成1 期

Safety and efficacy of inhaled sodium nitrite in patients with persistent asthma

Mahidol university0 个研究点目标入组 160 人开始时间: 2019年2月22日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
入组人数
160

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 75 Years(—)
性别
All

入选标准

  • Patients with persistent asthma with informed consent.
  • The eligible patients have persistent asthmatic symptoms (wheezing, cough, or shortness of breath) for at least 6 months, and must be able to do lung function test or body plethysmography.

排除标准

  • Patients with aspirin-induced asthma, exercise-induced asthma, history of bronchopulmonary dysplasia, smoking, fixed airflow obstruction determined by spirometry, any other serious respiratory diseases other than asthma, acute asthma exacerbation or respiratory tract infection within 4 weeks of visit 1, frequent use of albuterol as rescue medication (> 6 MDI puffs per day or > 3 nebulized treatment per day on more than 2 consecutive days), hypersensitivity to sodium nitrite or any components in the inhalation solution, any history of heart disease, any malignancy, narrow-angle glaucoma, moderate-to-severe renal impairment, unwilling to enroll or withdraw consent at any time of the study

研究者

相似试验